Edition:
United Kingdom

AcelRx Pharmaceuticals Inc (ACRX.OQ)

ACRX.OQ on NASDAQ Stock Exchange Global Market

3.63USD
19 Oct 2018
Change (% chg)

-- (--)
Prev Close
$3.63
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
307,926
52-wk High
$5.03
52-wk Low
$1.58

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.82 -0.203
Mar '18 0.34 -0.228
FY 2017 Dec '17 0.74 0.480
Sep '17 1.49 -0.281
Jun '17 2.66 -0.288
Mar '17 3.11 -0.343
FY 2016 Dec '16 6.43 -0.214
Sep '16 3.37 -0.252
Jun '16 4.53 -0.245
Mar '16 3.03 -0.242
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 6 5.96 20.32 0.00 4.87
Quarter Ending Mar-19 3 0.95 1.35 0.49 --
Year Ending Dec-18 7 8.03 22.06 1.00 22.09
Year Ending Dec-19 7 14.23 30.60 5.26 47.36
Earnings (per share)
Quarter Ending Dec-18 6 -0.21 -0.14 -0.28 -0.23
Quarter Ending Mar-19 3 -0.22 -0.19 -0.23 --
Year Ending Dec-18 5 -0.84 -0.78 -0.86 -0.94
Year Ending Dec-19 7 -0.84 -0.73 -1.00 -0.51
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.41 33.64
P/E High - Last 5 Yrs. -- 287.36 45.19
P/E Low - Last 5 Yrs. -- 89.75 23.75
Beta 3.03 0.93 0.88
Price to Sales (TTM) 14.87 124.37 5.83
Price to Book (MRQ) -- 15.29 4.89
Price to Tangible Book (MRQ) -- 14.52 6.51
Price to Cash Flow (TTM) -- 70.10 22.92
% Owned Institutions 39.70 14.25 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.54 5.40
Payout Ratio(TTM) -- 16.75 43.85

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -41.32 411.57 8.10
Sales (TTM) vs TTM 1 Yr. Ago -37.00 103.65 5.80
Sales - 5 Yr. Growth Rate 74.52 30.74 9.87
EPS (MRQ) vs Qtr. 1 Yr. Ago -17.56 24.06 23.38
EPS (TTM) vs TTM 1 Yr. Ago -79.25 -- --
EPS - 5 Yr. Growth Rate -- 37.62 10.92
Capital Spending - 5 Yr. Growth Rate 13.00 38.52 14.87

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 4.81 1.95 2.25
Current Ratio (MRQ) 4.92 5.36 3.05
LT Debt to Equity (MRQ) -- 34.93 12.76
Total Debt to Equity (MRQ) -- 36.74 17.18
Interest Coverage (TTM) -1.82 -96.75 37.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 13.88 40.09 54.87
Gross Margin - 5 Yr. Avg. -- 49.02 52.39
EBITD Margin (TTM) -225.81 -- --
EBITD - 5 Yr. Avg -161.51 -579.09 11.01
Operating Margin (TTM) -238.47 -786.66 4.07
Operating Margin - 5 Yr. Avg. -170.81 -600.20 6.34
Pre-Tax Margin (TTM) -319.40 -748.77 5.12
Pre-Tax Margin - 5 Yr. Avg. -212.89 -605.79 6.78
Net Profit Margin (TTM) -319.19 -749.75 1.39
Net Profit Margin - 5 Yr. Avg. -213.88 -608.47 3.03
Effective Tax Rate (TTM) -- 23.52 23.24
Effective Tax Rate - 5 Yr. Avg. -- 18.69 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 399,205 22,677,535 808,218,600
Net Income/Employee (TTM) -1,274,205 1,703,754 95,058,584
Receivable Turnover (TTM) 4.98 20.77 5.78
Inventory Turnover (TTM) 9.22 2.37 3.63
Asset Turnover (TTM) 0.16 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -51.83 -1.39 10.90
Return on Assets - 5 Yr. Avg. -34.34 3.03 12.01
Return on Investment (TTM) -63.23 0.21 14.27
Return on Investment - 5 Yr. Avg. -39.19 2.10 15.60
Return on Equity (TTM) -- 1.17 15.99
Return on Equity - 5 Yr. Avg. -81.78 2.74 16.87
  1 Year 3 Year 5 Year
Sales % -9.89 -16.21 74.52
EPS (TTM) % -72.93 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AcelRx Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 54.55 49.22 95 58
13 Week 142.86 131.03 98 61
26 Week 85.45 71.36 91 76
52 Week 35.64 14.96 71 47
YTD 96.15 72.26 85 59
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 9.96%
# of Holders: 67
Total Shares Held: 5,910,319
3 Mo. Net Change: 97,243
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 4
# Reduced Positions: 1
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.